Prolonged Overnight Oximetry in Obstructive Sleep Apnoea
PROXIMO
PROXIMO: A Cohort Study to Investigate the Incidence of Obstructive Sleep Apnoea Using Prolonged Overnight Oximetry in an Unselected Population Referred to Secondary Care Reporting Excessive Daytime Sleepiness
1 other identifier
interventional
200
0 countries
N/A
Brief Summary
This study is looking at the way in which patients with obstructive sleep apnoea (OSA) are diagnosed. The investigators current practice is to offer patients who are referred to the sleep centre with possible sleep apnoea a single night's oximetry recording. A decision is then made based on this screening test as to whether the patient has OSA, does not have OSA or requires a further investigation. There can be significant variation in the severity of OSA between nights. This study is designed to investigate if recording data from multiple nights will give any better indication on the presence and severity of obstructive sleep apnoea. Patients referred for overnight oximetry recordings that report excessive daytime sleepiness are eligible to enter the trial. On enrolment participants will all undergo a single night recording with the oximetry device currently in use by the recruiting sleep centre. In addition they will be asked to wear the prolonged recording oximeter (PRO) that allows for multiple nights data to be stored, and continue wearing this for a total of four nights. On returning both oximetry devices, this data will then be analysed and if it demonstrates evidence of OSA participants will return to the standard clinical pathway and be offered a trial of treatment with continuous positive airway pressure (CPAP) therapy. If no evidence of OSA is seen participants will also revert back to the standard clinical pathway, which may involve a further inpatient sleep investigation being arranged. The number of patients identified as having OSA based on the single first night recording will be compared to those identified as having OSA only after the additional nights recording. All participants will return to the current standard pathway of care on leaving the trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2020
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2020
CompletedFirst Posted
Study publicly available on registry
February 27, 2020
CompletedStudy Start
First participant enrolled
March 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2021
CompletedFebruary 27, 2020
February 1, 2020
1 year
February 19, 2020
February 26, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of OSA on 1 night vs 4 nights Oximetry
To compare the incidence of OSA using current single night recording versus multiple night recordings
4 days
Secondary Outcomes (2)
To compare the adherence rates to CPAP at 1 month follow-up
1 month
To assess the tolerability of prolonged oximetry screening for patients
4 days
Study Arms (1)
Overnight Oximetry
OTHERParticipants record simultaneously overnight oximetry on night 1 and continue with prolonged recordings alone for a total of 4 nights
Interventions
Simultaneous recording with a current standard oximeter (Minolta i300) and prolonged recording device. Comparison of data from first night and incidence of obstructive sleep apnoea identified from additional nights of recording identified.
Eligibility Criteria
You may qualify if:
- Willing to participate and give informed consent to participate
- Male or Female aged 18 years or older
- Referral letter or request to sleep service reports an Epworth Sleepiness Score of greater than 9 or reason for the referral is 'excessive daytime sleepiness'
You may not qualify if:
- Significant cardiovascular or respiratory co-morbidities
- Suspected hypoventilation or sleep disordered breathing
- Previously used Non-invasive ventilation
- In the Investigators opinion an alternative diagnostic test should be offered as first line e.g. referral information suggests an inpatient sleep study is required.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Justin Pepperell
Somerset NHS Foundation Trust
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant Physician in Respiratory and General Medicine; Honorary Senior Lecturer University of Exeter; Director of Department of Clinical Research; Secretary of the British Thoracic Society
Study Record Dates
First Submitted
February 19, 2020
First Posted
February 27, 2020
Study Start
March 1, 2020
Primary Completion
March 1, 2021
Study Completion
May 1, 2021
Last Updated
February 27, 2020
Record last verified: 2020-02
Data Sharing
- IPD Sharing
- Will not share